Effect of Lipoxin A_4 on IL-1β Production of Monocytes and Its Possible Mechanism in Severe Preeclampsia

This study examined in vitro effect of lipoxin A 4 (LXA 4) on interleukin-1β (IL-1β) production of monocytes and its possible mechanism in severe preeclampsia (PE).Peripheral venous blood was drawn from 15 patients with severe preeclampsia (PE group) and 20 normal pregnant women (control group) to prepare monocytes which were then treated with LXA 4 at different concentrations of 0,10,100 nmol/L respectively.IL-1β level in the supernatant of monocytes was detected by enzyme linked immunoassay.The [Ca 2+ ] i of monocytes was measured by laser scanning confocal microscopy.The results showed that the IL-1β level and the [Ca 2+ ] i of monocytes in the PE group were significantly higher than those in the control group.LXA 4 significantly decreased the generation of IL-1β in a dose-dependent manner in the PE group.After treatment with 100-nmol/L LXA 4,in the PE group,the [Ca 2+ ] i concentration of monocytes was significantly reduced.It was concluded that LXA 4 may inhibit the IL-1β production of monocytes from severe preeclampsia women by inhibiting extracellular calcium influx.

Maternal and Perinatal Complications of Severe Preeclampsia in Three Referral Hospitals in Yaoundé, Cameroon

Objective: The aim of this study was to determine maternal and perinatal complications of pregnancies complicated by severe preeclampsia in three tertiary care centers in Cameroon. Methods: We carried out a descriptive cross sectional study from the 1st of June 2012 to the 31th of June 2014, among pregnant women with severe preeclampsia followed up in three tertiary level hospitals in Yaoundé, Cameroon: the Yaoundé General Hospital, the Yaoundé Central Hospital, and the Yaoundé University Hospital. Statistical analysis was performed using EPI 3.5.5. Data were described as means ± standard deviation, percentages and numbers. Chi-square and Fisher exact tests were used where appropriate. Results: Of the 2500 deliveries registered during the study period, 111 cases (8.49%) were managed as severe preeclampsia. Four patients refused to participate and were excluded from the study. Most of these patients were non workers (58.0%), pauciparous (61.7%) and young (median age of 27.47 years ± 6.46). Eclampsia (12.14%), abruptio placentae (11.21%) and hypertensive retinopathy (7.47%) were the most frequent maternal complications. Two cases (1.86%) of maternal deaths occurred in patients who had eclampsia. Prematurity (48.6%), intra uterine fetal death (13.1%) and oligoamnios (11.2%) were the most frequent fetal complications. All four neonatal deaths occurred in women in whom the diagnosis of severe preeclampsia was done between 28 and 33 weeks of gestation. Conclusion: Pregnancies complicated by severe preeclampsia had significantly high maternal and perinatal morbidity and mortality in Cameroon. The complications of severe preeclampsia can be prevented by more widespread use of antenatal care, education of primary medical care personnel, prompt diagnosis of high-risk patients and timely referral to tertiary medical centers.

Impact of Adding Midazolam to Bupivacaine 0.5% in Regional Spinal Anesthesia on Maternal Middle Cerebral Artery Velocimetry in Parturients with Severe Preeclampsia

Severe preeclampsia is a challenging issue facing both intensivist and anesthetic team carrying both maternal and fetal morbidity and mortality. Termination of pregnancy after blood pressure control is the golden key in management. Cerebral complications due to diffuse cerebral vasospasm are most common and serious. Intrathecal midazolam with its gamma amino butyric action may antidote glutamate mediated sympathetic surge and decreasing cerebral vasospasm. Temporal view transcranial Doppler imaging maternal middle cerebral artery is used to examine blood flow indices namely pulsatility index and resistive index. One hundred ladies with severe preeclampsia scheduled for urgent caesarian section were recruited in 2 groups, both received 10 mg bupivacaine 0.5%, Midazolam group received 1 mg midazolam and the other group received 0.2 ml sterile saline 0.9% NaCl. All vascular indices were significantly better in midazolam group, less ICU stay.

HLA-G14 bp polymorphism Hainan Li nationality and severe preeclampsia susceptibility related research

Objective:To explore the correlation between the distribution of 14bp polymorphism in exon 8 of human leukocyte antigen-G(HLA-G)gene in Hainan Li nationality and susceptibility to severe preeclampsia.Methods:100 cases of severe preeclampsia inpatients(experimental group)admitted to our hospital from June 2018 to September 2019 were selected.Among them,50 were Li and 50 were Han,and 100 were admitted to our hospital during the same period Normal pregnant women were the control group,including 50 cases of Li nationality and 50 cases of Han nationality.Venous blood was collected to detect the 14bp polymorphism in HLA-G gene exon 8,and the correlation between the 14bp polymorphism in HLA-G gene exon 8 and susceptibility to severe preeclampsia was analyzed.Results:There was a statistically significant difference in the 14-bp genotyping and allele frequency in HLA-G exon 8 of the Li ethnic group in the control group and the experimental group(P<0.05).The SBP and DBP of the Li 14-14/14bp typing,+14bp/-14bp typing,and allele-14bp typing were lower in the experimental group than in the Han group in the experimental group(P<0.05),and the SBP of+14bp/-14bp typing DBP was higher than that of Han patients in the experimental group(P<0.05).Binary Logistic Regression Analysis+14bp/-14bp was associated with the incidence of severe preeclampsia in Li women in Hainan region(P<0.05).The-14bp/-14bp classification was a protective factor for severe preeclampsia in Li women in Hainan region(P<0.05).Conclusion:The HLA-G gene exon 8 carrying a 14bp deletion polymorphism in the Hainan Li nationality is associated with preeclampsia susceptibility and progression.

Influence of human albumin combined with low-dose heparin on disease condition, serology and placental blood flow of severe preeclampsia patients

Objective:To study the influence of human albumin combined with low-dose heparin on disease condition, serology and placental blood flow of severe preeclampsia patients. Methods:A total of 78 patients with severe preeclampsia in our hospital between May 2011 and February 2017 were chosen as study subjects, treatment methods were reviewed and all patients were divided into control group (n=37) who underwent low-dose heparin plus conventional treatment and observation group (n=41) who underwent human albumin combined with low-dose heparin plus conventional treatment, both lasting for 7 d. Before and after treatment, mean arterial pressure (MAP) and 24 h urinary protein were measured, serum markers of disease were measured by enzyme-linked immunosorbent assay (ELISA), and umbilical artery hemodynamics were detected by color Doppler ultrasound.Results:Before treatment, there was no significant difference between the two groups in MAP, 24 h urine protein, serum disease-related indexes or umbilical artery hemodynamic indexes. 7 d after treatment, MAP and 24 h urine protein levels in observation group were lower than those in control group;serum disease-related indexes TGF-β1 and VEGF contents in observation group were higher than those in control group whereas VCAM-1 and sFlt-1 contents were lower than those in control group;umbilical artery hemodynamic indexes PI, RI and S/D levels in observation group were lower than those in control group.Conclusion: Human albumin combined with low-dose heparin can optimize the disease condition, promote the angiogenesis of placenta and increase the blood supply of placenta in patients with severe preeclampsia.

Effect of magnesium sulfate combined with labetalol on the apoptosis and invasion molecule expression in placenta as well as maternal endothelial function of patients with severe preeclampsia

Objective: To investigate the effect of magnesium sulfate combined with labetalol on the apoptosis and invasion molecule expression in placenta as well as maternal endothelial function of patients with severe preeclampsia. Methods: A total of 68 patients with severe preeclampsia who were treated in the hospital between October 2015 and August 2017 were chosen as the research subjects and divided into study group (n=34) and control group (n=34) by random number table method. Control group received magnesium sulfate therapy on the basis of conventional therapy, and study group received magnesium sulfate combined with labetalol therapy on the basis of conventional therapy. The differences in the expression of apoptosis and invasion molecules in placenta tissue as well as the levels of maternal endothelial function indexes were compared between the two groups. Results: Fas, Bax and Caspase-3 mRNA expression in the placenta tissues of study group were lower than those of control group whereas Bcl-2 mRNA expression was higher than that of control group;GPR30, LAMA4 and MEST mRNA expression in placenta tissues were lower than those of control group whereas CDKN1C mRNA expression was higher than that of control group;24 h before delivery, maternal serum ET-1 and vWF levels of study group were lower than those of control group whereas NO level was higher than that of control group (P<0.05). Conclusion: Magnesium sulfate combined with labetalol therapy can effectively inhibit the apoptosis of placental trophoblast cells and enhance their invasion ability, and also improve the maternal endothelial function in patients with severe preeclampsia.

Effect of adjuvant low-molecular-weight heparin therapy on placental hypoxia and cell apoptosis in puerperae with severe preeclampsia

Objective:To study the effect of adjuvant low-molecular-weight heparin therapy on placental hypoxia and cell apoptosis in puerperae with severe preeclampsia.Methods:A total of 94 puerperae with severe preeclampsia who received treatment and safely gave birth in our hospital between May 2014 and May 2016 were selected as the research subjects and randomly divided into the LMWH group who received low-molecular-weight heparin combined with conventional symptomatic treatment and the control group who received conventional symptomatic treatment. Before and after treatment, serum was collected respectively to determine the levels of placental hypoxia-related cytokines, and after delivery, the placentas were collected to detect oxidative stress indexes and cell apoptosis indexes.Results: After treatment, serum PLGF and PAPP-A levels of both groups were significantly higher than those before treatment while sFlt-1 and sEng levels were significantly lower than those before treatment, and after treatment, serum PLGF and PAPP-A levels of LMWH group were significantly higher than those of control group while sFlt-1 and sEng levels were significantly lower than those of control group;ROS and RNS levels as well as Fas, FasL, caspase-3 and caspase-8 protein expression in placenta tissue of LMWH group were significantly lower than those of control group while GPx-1, SOD-1 and Trx levels as well as Survivin, XIAP and Bcl-2 protein expression were significantly higher than those of control group.Conclusion:Adjuvant low-molecular-weight heparin therapy can relieve the placental hypoxia, improve oxidative stress reaction and inhibit cell apoptosis in puerperae with severe preeclampsia.

Erratum to “Anesthetic Dilemma: Spinal Anesthesia in a Severe Pre-Eclamptic Patient with Twin Gestation, Heart Failure and Acute Pulmonary Edema”

Background: Severe preeclampsia with acute pulmonary oedema possesses great challenges to the anaesthetist. If not well managed, it could be associated with high maternal morbidity and mortality rate as well as fetal wastage. Aim: To sensitize the anaesthetist that when confronted with such a dilemma, well managed low spinal block can be a useful and successful anaesthetic technique. Methods: We report the case of a 23-year-old primigravida with twins gestation at 36 weeks, who presented with severe ante-partum pre-eclapsia, acute pulmonary oedema and acute heart failure. Blood investigations done were normal, and clotting time was within normal range. Her clinical conditions were optimized through a well thoughtful medication after which a low dose spinal anesthesia was performed using 1.5 mls (7.5 mg) of 0.5% hyperbaric bupivacaine (Modified saddle). The baby was delivered through a low segment caesarean section. Conclusion: The procedure was well tolerated and successful. Low spinal is associated with low incidence of hypotension and do not require pre-loading.

Anesthetic Dilemma: Spinal Anesthesia in a Severe Pre-Eclamptic Patient with Twin Gestation, Heart Failure and Acute Pulmonary Edema

Background: Severe preeclampsia with acute pulmonary oedema possesses great challenges to the anaesthetist. If not well managed, it could be associated with high maternal morbidity and mortality rate as well as fetal wastage. Aim: To sensitize the anaesthetist that when confronted with such a dilemma, well managed low spinal block can be a useful and successful anaesthetic technique. Methods: We report the case of a 23-year-old primigravida with twins gestation at 36 weeks, who presented with severe ante-partum pre-eclapsia, acute pulmonary oedema and acute heart failure. Blood investigations done were normal, and clotting time was within normal range. Her clinical conditions were optimized through a well thoughtful medication after which a low dose spinal anesthesia was performed using 1.5 mls (7.5 mg) of 0.5% hyperbaric bupivacaine (Modified saddle). The baby was delivered through a low segment caesarean section. Conclusion: The procedure was well tolerated and successful. Low spinal is associated with low incidence of hypotension and do not require pre-loading.

Rationale of a Cross-Sectional Descriptive Study on Associated Factors and Prognosis Maternal-Fetal Links to Early Onset Preeclampsia at the University Clinics of Kinshasa, DR Congo

Background: Preeclampsia (PE) is one of the forms of hypertensive diseases that occur during pregnancy. Early-onset preeclampsia (EOP), which occurred before 34 weeks, proved to be the deadliest. Indeed, it is characterized by a poor maternal and fetal prognosis. EOP has a disparate incidence in the world varying between 0.9% and 31%. Several risks factors are associated with the occurrence of EOP, which is responsible of several adverse obstetrical outcomes. Complications can affect up to 85% of pregnant women with EOP, especially when EOP appears very early, before 28 or even 25 weeks’ gestation. Objectives: To determine frequency of EOP at the University Clinics of Kinshasa, to describe sociodemographic and clinical characteristics of pregnant women with EOP and to identify its risks factors and its association adverse obstetrical outcomes. Methods: The study will be a cross-sectional analytical study in University Clinics of Kinshasa from January 2016 to December 2022. The minimal size will be 119. Our study population will consist of pregnant women who consult for antenatal best care and are neonates in our Clinic. Result will be presented as percentage proportion. Comparison and proportion means between groups will be made using Student’s test and Pearson’s chi-square test, respectively. Our test will be statistically significant for a p-value ≤ than less 0.05. Data will be collected and analysed anonymously and confidentiality. Conclusion: We believe that our study should enable us to identify profile of gestational carriers at risk of EOP in our environment, as well as prognosis associated with this entity, with a view to arousing particular interest in EOP.

主肺动脉收缩期加速时间/射血时间比值评估重度子痫前期胎儿肺成熟度

目的探讨胎儿主肺动脉收缩期加速时间(AT)/射血时间(ET)比值对重度子痫前期胎儿肺成熟度的预测价值。方法选取2021年1月至2022年12月因重度子痫前期在我院住院并自愿接受超声检查的孕妇65例,根据孕周分为早发型(孕20~33^(+6)周)重度子痫前期组(A组,n=30)和晚发型(孕34~40周)重度子痫前期组(B组,n=35)。选取超声检查孕周与A、B组相匹配的正常孕妇作为各自对照组(分别为30例、35例)。超声多普勒测量胎儿主肺动脉血流参数,包括AT、ET、AT/ET、收缩期峰值流速(PSV)。于分娩即刻采集羊水(约15 mL),检测羊水卵磷脂/鞘磷脂(L/S)值。比较A、B组胎儿主肺动脉血流参数及其与对照组有无差异,分析血流参数与羊水L/S的相关性。结果A组、B组胎儿主肺动脉AT、ET、AT/ET、PSV比较差异有统计学意义(P<0.05),且均小于各自对照组(均P<0.05)。A组、B组胎儿主肺动脉AT/ET比值与羊水L/S均呈正相关(r分别为0.821、0.383,均P<0.05)。受试者操作特征曲线分析显示AT/ET诊断早发型及晚发型子痫前期的曲线下面积分别为0.839、0.833,当假阳性率为5%时,灵敏度分别为0.853、0.912,特异度分别为0.583、0.611,截断值分别为0.185、0.255。结论胎儿主肺动脉AT/ET比值能对重度子痫前期做出初步诊断,并可定量评估胎儿肺成熟度,可为临床提供一种新的简单、无创、可重复的评估方法。

重度子痫前期患者胎盘组织中CD44 mRNA和CD24 mRNA及蛋白表达水平的临床价值研究

目的探讨重度子痫前期(severe preeclampsia,SPE)患者胎盘中细胞表面跨膜糖蛋白分子(cell surface transmembrane glycoprotein molecules,CD)44 mRNA,细胞表面跨膜糖蛋白分子24(CD24)mRNA及蛋白表达水平表达的临床价值研究。方法选取2019年6月~2022年6月在聊城市第二人民医院接受剖宫产分娩的SPE患者,根据发病孕龄的不同,进一步将其分为早发型SPE组(孕龄≤34周,n=45)和晚发型SPE组(孕龄>34周,n=55)。选取同期产检正常者100例为对照组。采用荧光定量PCR和免疫组织化学检测SPE患者胎盘中CD44和CD24表达,Pearson法分析其表达水平差异以及与SPE疾病临床特征的相关性,多因素Logistic回归分析发生SPE的影响因素。结果相较于对照组,SPE胎盘组织中CD44 mRNA(0.55±0.12 vs 1.02±0.33),CD24 mRNA的表达水平(0.68±0.19vs 1.05±0.11)均降低,差异具有统计学意义(t=13.385,16.853,P<0.05)。免疫组织化学染色结果显示,CD44,CD24在SPE组胎盘组织中多呈阴性表达或弱阳性表达,而在对照组中多呈阳性表达,且SPE胎盘组织中CD44,CD24阳性率低于对照组,差异具有统计学意义(χ^(2)=9.696,14.346,P<0.05)。相较于早发型SPE组,晚发型SPE胎盘组织中CD44(0.65±0.17 vs 0.42±0.11),CD24(0.77±0.23 vs 0.58±0.13)mRNA的表达水平均较高,差异具有统计学意义(t=7.830,4.932,P<0.05)。相较于对照组,SPE组BMI,收缩压、舒张压、尿蛋白、Cr,LDH和BUN均显著升高,差异有统计学意义(t=5.360~30.241,均P<0.05);SPE组分娩孕周较早、MPV,ALB较低、新生儿出生身长较短和体质量较轻均低于对照组,差异具有统计学意义(t=3.232~11.109,均P<0.05)。且SPE胎盘组织中CD44与CD24表达呈正相关(r=0.698,P<0.05),SPE胎盘组织中CD44的表达分别与CD24,分娩孕周、MPV和新生儿出生身长呈正相关(r=0.611,0.639,0.612,0.465,均P<0.05);与收缩压、尿蛋白和LDH呈负相关(r=-0.604,-0.569,-0.593,均P<0.05)。CD24的表达分别与分娩孕周、MPV和新生儿出生身长呈正相关(r=0.605,0.584,0.640,均P<0.05);与收缩压、尿蛋白和LDH呈负相关(r=-0.637,-0.593,-0.561,均P<0.05)。经Logistic回归分析结果显示,MPV(95%CI:1.429~4.350),尿蛋白(95%CI:1.529~2.709),LDH(95%CI:1.425~3.932)均是发生SPE的独立危险因素(均P<0.05)。高水平CD44(95%CI:0.561~0.940),CD24(95%CI:0.495~0.814)是发生SPE的独立保护因素(均P<0.05)。结论SPE患者胎盘中CD44,CD24表达水平较低,高水平CD44,CD24均是SPE发生的独立保护因素,可为后续SPE的治疗提供方向。

拉贝洛尔联合低分子肝素对早发型重度子痫前期孕妇凝血功能及血压的影响

目的探究拉贝洛尔联合低分子肝素对早发型重度子痫前期孕妇凝血功能及血压影响。方法选取2021年1月至2022年7月济南市第一人民医院收治的80例早发型重度子痫前期患者作为研究对象,随机分为A组与B组,每组40例。A组给予拉贝洛尔治疗,B组给予拉贝洛尔联合低分子肝素治疗。比较两组治疗前后凝血功能指标、血压、血脂水平、母婴结局、新生儿Apgar评分及不良反应发生情况。结果治疗后,B组凝血酶原时间(PT)、凝血酶时间(TT)、活化部分凝血活酶时间(APTT)均长于A组,新生儿5、10 min Apgar评分均高于A组,纤维蛋白原(FIB)、收缩压(SBP)、舒张压(DBP)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)水平及不良新生儿结局、不良妊娠结局发生率均低于A组,差异有统计学意义(P<0.05)。两组不良反应发生率比较差异无统计学意义。结论拉贝洛尔联合低分子肝素治疗早发型重度子痫前期,可改善患者凝血功能、血脂及血压水平,改善母婴结局,且安全性较高。

限制性液体管理策略在重度子痫前期术后快速康复的应用价值

目的探讨限制性液体管理策略在重度子痫前期术后快速康复中的应用价值。方法回顾性分析2018年1月至2023年1月江西省妇幼保健院收治的100例重度子痫前期患者的临床资料,按就诊时间的不同分为研究组(2019年5月至2023年1月)与对照组(2018年1月至2019年4月),每组各50例。对照组实施限常规液体管理,研究组实施限制性液体管理。比较两组患者的严重并发症的发生率、血压值下降效果、术后住院时间及术后ICU住院时间。结果研究组的心力衰竭、肺水肿、黑尔普(HELLP)综合征的发生率均低于对照组,差异有统计学意义(P<0.05);研究组的血压下降总有效率高于对照组,差异有统计学意义(P<0.05);研究组的术后住院时间及术后ICU住院时间均短于对照组,差异有统计学意义(P<0.05)。结论限制性液体管理策略可减少重度子痫前期术后严重并发症的发生,可更快地使血压下降到目标值,缩短住院时间,从而起到促进重度子痫前期术后快速康复的作用。

外周血SII、LMR与子痫前期严重程度相关性及其预测价值

目的探讨外周血全身免疫-炎症指数(SII)、淋巴细胞/单核细胞比值(LMR)与子痫前期患者严重程度相关性及其预测价值。方法选取102例子痫前期孕妇进行研究,其中58例轻度子痫患者为轻度组,44例重度子痫患者为重度组;另选取同期50例健康体检孕妇为对照组。比较各组外周血SII、LMR水平;采用Pearson相关性分析SII、LMR与子痫前期严重程度的相关性,并用ROC评估血清SII、LMR单独和联合检测诊断子痫前期的价值。结果轻度组、重度组血清SII水平均高于对照组(P<0.05),LMR水平均低于对照组(P<0.05);重度组血清SII水平高于轻度组,血清LMR水平低于轻度组(P<0.05)。轻度组、重度组的血压水平均高于对照组,且重度组高于轻度组(P<0.05)。血清SII与子痫前期严重程度呈正相关,血清LMR与子痫前期严重程度呈负相关(P<0.05)。SII诊断子痫前期的灵敏度为70.59%,特异度为59.05%;LMR诊断子痫前期的灵敏度为76.47%,特异度为40.16%;SII+LMR联合诊断的灵敏度为93.14%,特异度为31.49%。SII、LMR及SII+LMR联合检测诊断子痫前期的AUC分别为0.940、0.960和0.970。结论外周血SII与子痫前期患者严重程度呈正相关,LMR与子痫前期患者严重程度呈负相关,二者联合诊断子痫前期的灵敏度较高,对子痫前期的发生具有一定的预测价值。

孕妇外周血miR-152 miR-210与子痫前期病情程度及妊娠结局的相关性研究

目的:探究孕妇外周血微小RNA-152(miR-152)、miR-210与子痫前期(PE)病情程度及妊娠结局的相关性。方法:选取2018年7月至2022年5月我院200例PE患者,根据病情严重程度分为轻度组(轻度PE患者,n=114)和重度组(重度PE患者,n=86),另选同期、同年龄段健康孕妇作为对照组(n=100)。比较三组血压[收缩压(SBP)、舒张压(DBP)]、24h尿蛋白定量(24h Upro)、钙离子(Ca^(+))、外周血miR-152、miR-210水平,分析外周血miR-152、miR-210水平与PE病情程度、血压、24h Upro及Ca^(+)相关性。PE患者随访至妊娠结束,比较不同妊娠结局PE患者临床资料、外周血miR-152、miR-210水平,通过Lasso回归和Logistic回归分析预测因素与不良妊娠结局的关联性,通过受试者工作特征曲线(ROC)、临床决策曲线(DCA)评价外周血miR-152、miR-210对预测PE患者发生不良妊娠结局的价值及临床效用。结果:重度组、轻度组、对照组SBP、DBP、24h Upro、外周血miR-152、miR-210水平比较,差异有统计学意义(P<0.05);外周血miR-152、miR-210水平与PE病情程度、血压、24h Upro呈正相关(P<0.05),与Ca^(+)水平呈负相关(P<0.05);发生不良妊娠结局年龄、流产史、病情程度、SBP、DBP、24h Upro、Ca^(+)、外周血miR-152、miR-210水平与未发生不良妊娠结局患者比较,差异有统计学意义(P<0.05);Lasso回归选出5个预测变量为病情程度、SBP、24h Upro、外周血miR-152、miR-210水平;Logistic回归显示,外周血miR-152、miR-210水平是PE患者发生不良妊娠结局的独立危险因素(P<0.05);ROC、DCA结果显示,外周血miR-152、miR-210联合预测PE患者发生不良妊娠结局具有良好的预测价值和临床效用。结论:外周血miR-152、miR-210在PE患者中表达上调,且与病情程度、妊娠结局显著相关,其联合预测患者发生不良妊娠结局具有一定参考价值和临床效用。

重度子痫前期并发心功能不全的危险因素分析

目的探究重度子痫前期(severe preeclampsia,sPE)出现心功能不全相关的危险因素。方法选取2020年1月至2023年9月于温州市中心医院住院的sPE并发心功能不全的患者32例作为实验组,并随机选取同时期心功能正常的sPE患者75例作为对照组。比较两组患者的一般资料和实验室指标的差异,采用二元Logistic回归分析探讨sPE出现心功能不全的危险因素。结果实验组患者出现呼吸衰竭、血管内溶血-肝酶升高-低血小板、感染的例数高于对照组,差异有统计学意义(P<0.05)。对照组发生新生儿窒息、新生儿转重症监护的例数高于实验组,差异有统计学意义(P<0.05)。两组患者的孕前体质量指数、孕期体质量增幅、血钙、白蛋白、血红蛋白、双胎、感染差异有统计学意义(P<0.05),二元Logistic回顾分析结果显示,孕前体质量指数增加、孕期体质量增幅≥20kg、低血钙、低白蛋白、中度贫血、孕期血压增加是sPE出现心功能不全的危险因素。结论孕期应积极控制血压、补钙、补铁、补充白蛋白、控制体质量;对sPE患者增加血钙、白蛋白、血红蛋白、血压相关指标监测的频率,积极控制血压、解痉、预防感染可减少sPE患者心功能不全的发生。

妊娠期糖尿病患者孕期维生素A、E水平与重度子痫前期的相关性

目的探究妊娠期糖尿病患者孕期维生素A、E水平变化与重度子痫前期的相关性。方法回顾性分析162例妊娠期糖尿病患者的临床资料,测定其建卡当天(T_(1))和确诊时(T_(2))的维生素A、E水平,并依据T_(2)时患者有无子痫前期分为对照组(未合并子痫前期,76例)及研究组(合并子痫前期,86例)。对比两组患者各时点维生素A、E水平,分析孕期维生素A、E水平与重度子痫前期的相关性。结果T_(2)时,研究组维生素A、E水平均低于对照组(P<0.05)。T_(2)时,研究组中子痫前期者占比55.81%,重度子痫前期者占比44.19%。T_(1)及T_(2)时,重度子痫前期组维生素A、E水平均低于子痫前期组(P<0.05)。Logistic回归分析结果显示,缺乏维生素A、E会影响重度子痫前期的进展(P<0.05)。结论临床可考虑以孕期维生素A、E水平为依据对妊娠期糖尿病合并子痫前期严重与否进行判断,以便积极采取早期治疗。

改良早期预警评分联合快速反应系统在重度子痫前期患者中的应用效果

目的探讨改良早期预警评分(MEWS)联合快速反应系统(RRS)对重度子痫前期(SPE)患者的应用效果。方法采集南京市第一医院产科2019年5月至2021年6月收治的252例SPE患者的临床资料,将2019年5月至2020年6月急诊就诊行RRS干预的126例SPE患者作为对照组,将2020年7月至2021年6月急诊就诊行MEWS联合RRS干预的126例SPE患者作为干预组。比较两组实施救治时间、终止妊娠孕龄、分娩方式、住院时间、并发症发生情况及围生儿结局。结果干预组实施救治时间、住院时间短于对照组,终止妊娠孕龄、自然分娩占比高于对照组(P<0.05)。干预组HELLP综合征、胎盘早剥、肝肾损伤、产后出血发生率低于对照组(P<0.05);两组静脉血栓栓塞发生率比较,差异无统计学意义(P>0.05)。干预组胎儿早产、胎儿窘迫、新生儿窒息、低体重儿发生率低于对照组(P<0.05);两组围生儿病死率比较,差异无统计学意义(P>0.05)。结论MEWS联合RRS可提高SPE患者实施救治速度,缩短住院时间,降低并发症发生率,改善患者妊娠结局及围生儿结局,临床应用效果较佳。

血清HDAC6和FoxO3a蛋白水平在预测妊娠期糖尿病并发重度子痫前期中的临床价值

目的探究血清组蛋白去乙酰化酶6(HDAC6)和叉头框O3a(FoxO3a)蛋白水平在预测妊娠期糖尿病(GDM)并发重度子痫前期(sPE)中的临床价值。方法选取2021年7月至2022年7月在广元市第一人民医院分娩的224例单胎妊娠孕妇作为研究对象。其中GDM孕妇78例为GDM组,GDM并发sPE孕妇76例为GDM-sPE组,正常孕妇70例为对照组。采用酶联免疫吸附试验(ELISA)法检测血清HDAC6和FoxO3a的蛋白水平;采用Pearson法分析GDM-sPE患者血清HDAC6和FoxO3a的相关性;绘制受试者工作特征(ROC)曲线分析HDAC6和FoxO3a对GDM-sPE的预测价值。采用Logistic回归分析GDM-sPE发生的影响因素。结果GDM-sPE组HDAC6和FoxO3a水平均显著高于GDM组和对照组,GDM组显著高于对照组(P<0.05)。相关性分析显示,GDM-sPE患者血清HDAC6和FoxO3a的表达水平呈正相关(r=0.569,P<0.001)。ROC曲线分析显示,二者联合预测GDM-sPE发生的曲线下面积(AUC)高于HDAC6和FoxO3a单独预测的AUC(Z=24.214,P<0.001;Z=19.601,P<0.001)。Logistic回归分析显示,FBG、HDAC6和FoxO3a是GDM-sPE发生的影响因素(P<0.05)。结论GDM-sPE患者血清HDAC6和FoxO3a表达水平均显著升高,二者联合对GDM-sPE具有一定的预测价值。